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Note, The EC Hormone Ban Dispute and the Application of the
Dispute Settlement Provisions of the Standards Code
Allen Dick*
INTRODUCTION
As the concept of a unified European market becomes more of a
reality as we approach 1992, talk of a "Fortress Europe" has height-
ened sensitivity on trade issues among officials of the United States
and the European Community ("EC"). I The EC's plan to ban the sale
of meat treated with growth hormones within the Member-States has
presented a trade issue disconcerting to both sides. This brewing tem-
pest has raised many interesting legal issues involving the dispute set-
tlement provisions set out in the Agreement on Technical Barriers to
Trade ("Standards Code"). 2 This note examines why the process
failed to resolve, and thus contain, the dispute between the United
States and the EC, and offers some tentative proposals for reform.
BACKGROUND
As with many other trade disputes, one is not sure whether the
politics are driven by the legal issues, or vice versa. The diplomatic
activity surrounding the hormone ban dispute has been fairly intense
over the past two years and continues to be so to this very day.
A directive adopted by the EC in late December, 1985, entitled
"Council Directive Prohibiting the Use in Livestock Farming of Cer-
tain Substances Having a Hormonal Action," marked the beginning of
the trade dispute.3 The directive prohibited the importation from
third countries of meat from animals which had been administered a
substance with a "thyrostatic, oestrogenic, androgenic or gestagenic
action."' 4 In laymen's terms, the EC banned the use of hormones for
growth or fattening purposes. This import ban was pronounced to
take effect on January 1, 1988. 5 The impetus for the hormone ban was
an effort to harmonize the divergent Member-States' legislation on this
* University of Michigan Law School, Class of 1989.
1. As one might suspect, the EC has tried to placate these fears. See 5 Int'l Trade Rep.
(BNA) 1416 (Oct. 26, 1988).
2. CONTRACTING PARTIES TO GATT, Basic Instruments & Selected Documents, 26th Supp.
at 8 (1980) (hereinafter "Standards Code"). Both the EC and the United States are signatories to
this agreement.
3. 28 O.J. EUR. COMM. (No. L 382) 228 (1985).
4. Id. art. 6(1).
5. Id. art. 6(2).
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topic.6 Some Member-States felt that a ban on the use of hormones in
meat represented an appropriate policy due to the uncertainties sur-
rounding the scientific research pertaining to its effect on humans.
7
Since other Member-States had differing assessments of the hormones'
effect and therefore permitted their use, a market distortion resulted
which created a "serious barrier to intra-Community trade." The
Commission chose to harmonize the Member-State legislation essen-
tially by adopting a "no-risk" policy. It completely banned the sale of
meat within the EC which had been treated with growth hormones. 9
The United States responded with outrage. The ban's implementa-
tion had the potential of eliminating $120 million worth of American
meat exports to the EC.10 More importantly, the United States felt
that the ban was not based on any valid scientific evidence, and thus
constituted a non-tariff barrier to trade."I
After bilateral negotiations failed to resolve the dispute, the United
States began to operate within the framework of the Standards Code.
In January 1987, the United States requested consultations with the
EC under Article 14.1 of the Code. ' 2 After several months of fruitless
consultations, the United States requested that the GATT Committee
on Technical Barriers to Trade ("Committee") investigate the mat-
ter. ' 3 This mechanism also failed to yield a satisfactory solution to the
problem. Finally, on July 15, 1987, the United States asked for the
formation of a Technical Expert Group to examine the technical issues
of the dispute. 14 The EC, however, succeeded in blocking the forma-
tion of the Technical Expert Group by vehemently objecting to it in
the Committee meeting.' 5 The EC, to this day, refuses to consider the
implementation of this procedure.'
6
Exasperated with the failure of the dispute resolution mechanism
under the Standards Code, the United States resorted to unilateral
measures. It threatened to retaliate under section 301 to break the
6. The Preamble to the directive states in paragraph 5:
[W]hereas while their immediate effect on animals from the farmer's point of view is clear,
assessments of their effect on human health vary and this is reflected in the regulations
governing their use; whereas this divergence distorts the conditions of competition in prod-





9. Id. arts. 4-6.
10. 4 Int'l Trade Rep. (BNA) 1184 (Sept. 30, 1987).
11. Id.




16. Int'l Trade Daily (BNA) 5 (Nov. 29, 1988).
Summer 19891
Michigan Journal of International Law
deadlock which had developed. On September 14, 1987, the United
States offered to refrain from retaliation if the EC either agreed to
submit the dispute to the Technical Expert Group under the Stan-
dards Code or acceded to a one-year postponement of the ban.
17
The EC initially characterized this proposal as "totally unaccept-
able."' 8 Nevertheless, on November 18, 1987, the EC agricultural
ministers agreed to delay implementation of the proposed ban until
January 1, 1989, despite objections from Belgium, Greece, Ireland,
and Spain. 19 The EC claimed that this delay was for purely internal
reasons concerning the ban's implementation. 20 One problem which
the ministers foresaw was the large quantities (up to 600,000 tons) of
beef in public storage which had been treated with growth hormones.
This meat would have become unmarketable after the ban went into
effect, resulting in large losses to Member-State governments. French
producers who could still lawfully use growth hormones up to the Jan-
uary 1 deadline, but who would be denied a market for the hormone-
treated meat after the deadline, presented a similar problem. Regard-
less of the reason why the EC delayed the implementation of the ban,
this action at least provided some breathing space for negotiators, who
now had an extra year to find a solution to the conflict.
This sense of relief was short-lived. On November 23, 1987, Presi-
dent Reagan triggered the section 301 mechanism by instructing the
United States Trade Representative to hold a public hearing regarding
a list of goods to target for possible economic retaliation against the
hormone ban. 21 The Office issued the final list on December 24, 1987.
It included various agricultural goods whose estimated total value was
$100 million, an amount equal to the expected loss to American pro-
ducers from the hormone ban.
22
An interesting development occurred in late February 1988. The
European Court of Justice ("ECJ") upheld a challenge to the hormone
ban brought by the United Kingdom and Denmark.23 The ECJ
voided the directive due to an improper voting procedure used in its
adoption. Unfortunately for the United States, the ECJ did not ad-
dress the substantive issues of whether the import ban violated the
Treaty of Rome or whether it was based on scientific evidence. 24 The
ECJ decision did, however, provide a ray of hope to United States
17. 4 Int'l Trade Rep. (BNA) 1184 (Sept. 30, 1987).
18. Id.
19. 4 Int'l Trade Rep. (BNA) 1453 (Nov. 25, 1987).
20. See Id.
21. 4 Int'l Trade Rep. (BNA) 1488 (Dec. 2, 1987).
22. 5 Int'l Trade Rep. (BNA) 16 (Jan. 6, 1988).
23. Cour de Justice des Communautes Europeennes, Arret de la Cour, Affaire 68/86 du 23
Fevrier 1988 (LEXISINTNAT-CJCE), reported in 5 Int'l Trade Rep. (BNA) 237 (Feb. 24,
1988).
24. There was pending a substantive challenge to the directive brought by a French manufac-
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negotiators, who felt that the voiding of the directive offered the EC a
politically painless end to the dispute. Their hopes were dashed,
though, when the EC reenacted an identical directive after only a fif-
teen minute discussion, with only the United Kingdom dissenting.
25
In November 1988, the United States again raised the stakes by
threatening to ban all EC meat imports in addition to the section 301
action. The United States negotiators claimed that this action was jus-
tified under either of two theories. First, the Reciprocal Meat Inspec-
tion provision (RMI) in section 4604 of the 1988 Omnibus Trade and
Competitiveness Act provided a statutory basis for trade sanctions
against the EC.26 The RMI permits the United States to ban tempo-
rarily the meat imports from any country which imposes standards on
United States exports "that are not related to public health concerns
... that can be substantiated by reliable analytical methods. '' 27 Sec-
ond, the administrative burden necessitated by the hormone ban was
alleged by the United States to be so great that the EC would not be
able tolprevent the export of meat to the United States which would
meet the American inspection standards. 28 Refusing to back down to
United States pressure, the EC proclaimed that it planned to retaliate
against an estimated $361 million worth of American goods if the
United States attempted to block the importation of meat from the
EC.29 "..-
These were the parties' positions on the dispute when they met in
Brussels on November 18-19, 1988. There, the EC proposed a solu-
tion by which the EC would exclude from the directive meat used for
pet foods, and raise the so-called "Hilton quota" on high quality
beef.30 The United States rejected the proposal, and stated that the
United States' response to these measures would only be a reduction in
the dollar amount of goods against which the United States would
retaliate. 3'
This was the last attempt at resolving this escalating trade dispute.
The EC and the United States were expected to discuss the topic again
in Montreal a week prior to the review of progress on the Uruguay
Round of talks.
32
turer of hormones called Distrivet S.A. 5 Int'l Trade Rep. (BNA) 237-38 (Feb. 24, 1988). How-
ever, the fate of this challenge was not known at the time of this Note.
25. 31 O.J. EUR. COMM. (No. L 70) 16 (1988).
26. 5 Int'l Trade Rep. (BNA) 1447 (Nov. 2, 1988).
27. Act of Aug. 23, 1988, Pub. L. No. 100-418, § 4604.
28. Int'l Trade Daily (BNA) 9-10 (Nov. 23, 1988).
29. Id. at 10.
30. Int'l Trade Daily (BNA) 2 (Nov. 29, 1988).
31. Id.
32. N.Y. Times, Dec. 1, 1988, at 34, col. 6.
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LEGAL ISSUES
As can be seen by its history, the EC hormone ban trade dispute is
another example of the frequent scenario where a relatively minor
trade dispute builds and builds into a major trade war once a state
takes or threatens unilateral sanctions. In this instance, had the
United States successfully invoked the dispute resolution mechanism
of the Standards Code, it is highly unlikely that the EC would pres-
ently be considering economic retaliation against $360 million worth
of American goods, or almost three times the initial value of the dis-
pute. One needs to ask what flaws, if any, exist within the procedural
structure of the Standards Code which resulted in its failure to resolve
this particular dispute. A step by step procedural analysis will facili-
tate the discussion.
The Standards Code establishes five phases of dispute resolution.
The first phase calls for "prompt" bilateral consultations pursuant to
section 14.2. 33 The United States and the EC held bilateral consulta-
tions in the months of February and April of 1987, but met with no
success. 34
The second phase calls for the convening of the GATT Committee
on Technical Barriers to Trade to investigate the matter.35 The Com-
mittee met from May, 1987 to September, 1987, but failed to, yield a
satisfactory solution. The United States blamed "EC insistence,
against the weight of scientific evidence, that consumption of meat
from animals treated with growth hormones is dangerous to human
health."
36
Where the dispute concerns questions of a technical nature, as
here, the Standards Code requires a third phase. This entails the for-
mation of a Technical Expert Group in accordance with article 14.9. 37
33. Article 14.2 provides:
Each Party shall afford sympathetic consideration to and adequate opportunity for prompt
consultation regarding representations made by other Parties with respect to any matter
affecting the operation of this Agreement.
Standards Code, supra note 2, at 22.
34. 52 Fed. Reg. 45,304 (1987).
35. Article 14.4 states:
If no solution has been reached after consultations under Article 14, paragraphs 1 and 2, the
Committee shall meet at the request of any Party to the dispute within thirty days of receipt
of such a request, to investigate the matter with a view to facilitating a mutually satisfactory
solution.
Standards Code, supra note 2, at 23.
36. 52 Fed. Reg. 45,304 (1987).
37. Article 14.9 provides:
If no mutually satisfactory solution has been reached under the procedures of Article 14,
paragraph 4 within three months of the request for the Committee investigation, upon the
request of any Party to the dispute who considers the issues to relate to questions of a
technical nature the Committee shall establish a technical expert group. .
Standards Code, supra note 2, at 23.
[Vol. 10:872
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One of the duties of the Technical Expert Group specified in the Stan-
dards Code is to:
make such findings as will assist the Committee in making recommenda-
tions or giving rulings on the matter, including inter alia, and if appro-
priate, findings concerning the detailed scientific judgments involved,
whether the measure was necessary for the protection of human, animal,
or plant life or health, and whether a legitimate scientific judgment is
involved.
38
On July 15, 1987, the United States requested the formation of a Tech-
nical Expert Group to examine the scientific judgment involved in the
EC's decision to ban the importation of meat treated with growth hor-
mones.39 In the United States' view, the formation of the expert group
should have been automatic due to language in the Code such as
"upon the request of any party" and "the Committee shall estab-
lish."' 40 The EC, however, disagreed. It argued that since the forma-
tion of a Technical Expert Group was an act of the Committee and
since the Committee only acted in consensus, its objection to the for-
mation of the expert group was fatal a.4
The EC's argument eventually prevailed. The EC's ability to block
the formation of the Technical Expert Group reveals the first flaw in
the dispute resolution process of the Standards Code. By requiring the
Committee to act only in consensus when faced with dispute resolu-
tion issues, article 14 of the Standards Code is doomed to failure. By
definition, conflicting views on the merits of any dispute will exist.
Thus, it is inconceivable that a consensus could be reached if the dis-
putants themselves are allowed to vote in the Committee. Only in the
relatively rare cases where self-interest causes both disputants to resort
to article 14, due to convenience or speed for example, will there not
be an attempt to block the dispute settlement mechanism. This criti-
cism parallels that of a GATT commentator, Bourgeois, who posits
that the casting of panels in the dual roles of conciliator and adjudica-
tor often compromises the adjudicatory function, because parties will
seek to avoid a legal ruling which is politically damaging. 42 It also
reflects one of the basic principles of jurisprudence that one cannot be
the judge of one's own cause. To remedy this situation, directly af-
38. Id.
39. 52 Fed. Reg. 45,304 (1987).
40. Telephone interview with Donald S. Abelson, former Director of Technical Trade Barri-
ers, Office of the United States Trade Representative (Dec. 1, 1988) (hereinafter "Abelson Inter-
view"); telephone interview with Suzanne M. Troje, Director of Technical Barriers to Trade,
Office of the United States Trade Representative (Nov. 30, 1988) (hereinafter "Troje Interview").
Donald Abelson handled the Standards Code issues at the beginning of the EC hormone ban
dispute. He has since moved on and now Suzanne Troje is responsible for Standards Code issues
at the USTR.
41. Abelson Interview, supra note 40; Troje Interview, supra note 40.
42. Bourgeois, The Tokyo Round Agreements on Technical Barriers and on Government Pro-
curement in International and EEC Perspective, 19 COMMON MKT. L. REV. 5, 18 (1982).
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fected parties should be required to abstain from voting when faced
with dispute resolution issues.
The nature of the EC's objection to the formation of the expert
group exposes a second shortcoming of the Standards Code. The EC's
objection was essentially a jurisdictional one. It claimed that the ban
on the importation of meat treated with growth hormones was a re-
quirement in terms of a "process and production method" ("PPM").
Thus the Standards Code did not govern, since its scope only included
"standards", i.e, requirements in terms of the characteristics of the
product, and expressly excluded PPMs. 43 The EC further argued that
the hormone ban, if subject to review at all, only required compliance
with GATT, notably article Ill.
44
The EC's claim that the Standards Code excludes PPMs from its
scope is generally a valid one. The Code's drafters expressly excluded
PPMs mainly because they were intensively used in the agricultural
sector, and the signatories did not want this highly sensitive area to be
subject to the Standards Code.4 5 The United States countered this ar-
gument at the negotiating table by citing article 14.25: "the dispute
settlement procedures set out above can be invoked in cases where a
Party considers that obligations under this Agreement are being cir-
cumvented by the drafting of requirements in terms of processes and
production methods rather than in terms of characteristic of prod-
ucts." 46The United States asserted that, according to article 14.25,
PPMs can be brought under the dispute settlement provisions without
question due to the language "can be invoked in cases where a Party
considers," since it implies that the challenging party must only have a
subjective belief that a Party is evading the Standards Code's substan-
tive obligations by drafting the requirement in terms of a PPM.47 This
was certainly the case with the United States, which believed that the
EC was trying to circumvent the jurisdiction of the Standards Code by
drafting the directive in terms of "meat treated with hormones," a
PPM, rather than meat with a specified maximum level of chemical
residues, a standard. Either would have been equally effective in
43. Abelson Interview, supra note 40. An example to help clarify the distinction between a
standard and a PPM is as follows. Suppose a country wished to regulate candy canes. It could
draft its regulation in terms of "candy made from syrup and heated to 250 degrees." This would
be a PPM since it is defining the product in reference to the process and production method used
in making candy canes. On the other hand, the regulation could be phrased to cover "candy
which is hard and which has red stripes." This would be a standard since the regulation is
defined in terms of the characteristics of the good.
44. Id.
45. Id.
46. Standards Code, supra note 2, at 26.
47. Abelson Interview, supra note 40; Report to the U.S. Congress on the Agreement on
Technical Barriers to Trade - "Standards Code" 12 (Jan. 1980 to Dec. 1982) (on file at the
MICH. J. INT'L L.) (hereinafter "First Triennial Report").
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achieving the directive's goal.48 In the United States' opinion, the ju-
risdictional objection to the formation of the Technical Expert Group
lacked merit, since article 14.25 subjected the EC directive to review
even though drafted in terms of a PPM.
As one might suspect, the EC read article 14.25 differently. The
EC pointed to a French version of the Standards Code where the Eng-
lish word "circumvent" carries with it a volitional element. 49 In the
EC's view, article 14.25 can only be invoked upon the showing of an
intent on the part of a signatory to evade its obligations under the
Standards Code. 50 Moreover, the EC regarded the United States' po-
sition as a "shoot first, ask questions later" policy, because the United
States continually pushed for the formation of the Technical Experts
Group before resolving the interpretation of article 14.25.
51
The United States responded to both of these claims by first stating
that it would be impossible for a challenging country to prove an ele-
ment of intent, and thus, the dispute settlement procedures could
never be invoked to challenge a PPM. 52 Furthermore, in response to
the equity argument, the United States expressed a similar negative
view of the opposing side's behavior, charging the EC with trying to
change the rules of the game in the heat of battle to suit its needs.53
The subsequent history of the EC hormone ban dispute, with the
United States threatening unilateral retaliation and the EC preparing
to counter-retaliate, demonstrates that the clash over the proper inter-
pretation of article 14.25 and the resulting scope of application of the
Standards Code must be resolved. The lack of a concrete interpreta-
tion of article 14.25 creates a loophole in the Standards Code whereby
parties to the agreement can evade its jurisdiction by drafting internal
requirements in terms of a PPM, and then insisting on an interpreta-
tion of 14.25 which calls for an almost impossible proof of intent. The
size of this loophole can be appreciated when one considers that nearly
every internal regulation drafted in the form of a standard can easily
be drafted as a PPM. The hormone ban directive bears this out, since
a regulation framed in terms of the residue level would have been
equally effective in achieving its goal.
The dispute over the correct interpretation of article 14.25 resulted
in trade tensions once before. Several years ago, the United States ini-
tiated the dispute settlement process in a case involving the immersion
48. Abelson Interview, supra note 40; Troje Interview, supra note 40.
49. Abelson Interview, supra note 40.
50. Id; First Triennial Report, supra note 47, at 12.
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chilling of poultry, the so-called "Spin Chill" case.5 4 Bilateral talks set
the contours of the PPM issue detailed above, but the case did not
proceed to review by Committee." However, in a subsequent meeting
of the Committee on October 4-5, 1983, certain ambiguous "conclu-
sions" were reached with respect to the interpretation of article
14.25.56 One view of what was actually resolved at this meeting is that
the Committee "agreed to cooperate" in cases involving PPMs.17 An-
other is a statement in an official United States document that the
Committee decided that PPMs may be brought under the dispute set-
tlement provisions of article 14.58 The EC hormone ban dispute was
the first test of this understanding59 , and the Committee, in all likeli-
hood, must be discouraged by the result.
One, however, suspects that any attempt to close the loophole cre-
ated by the lack of a definitive interpretation of article 14.25 would be
met with the same fierce opposition formed in the past. Two explana-
tions can be offered to clarify the problem. First, one can return to the
origin of the PPM exclusion and claim that parties to the Standards
Code still do not want to see its application in the hypersensitive area
of agriculture. However, the parties could append a savings clause to
the Standards Code to close the loophole, thereby creating grandfather
rights in the agricultural sector and simultaneously preventing coun-
tries from skirting their treaty obligations through artful legislative
drafting.
A second, more persuasive explanation is the different substantive
treatment given an internal regulation, depending upon whether or not
the scope of the Standards Code encompasses the regulation. If an
internal regulation is adjudged to be outside the scope of the Standards
Code, as most if not all of the PPMs are classified, then that regulation
will only be subject to the provisions of GATT, notably article III.
When one compares the substantive obligations of article III to those
of the Standards Code, one discovers that it is much more difficult to
challenge an internal regulation under article III of GATT.
This can be clearly shown in the context of the EC hormone ban
dispute itself. What follows is a comparison of the substantive obliga-
tions of the Standards Code and those of article III of GATT, as ap-
plied to the facts of this dispute. This comparison will provide clear
54. First Triennial Report, supra note 47, at 14; CONTRACTING PARTIES TO GATT, Basic
Instruments and Selected Documents, 27th Supp. 39 (1981).
55. First Triennial Report, supra note 47, at 14; CONTRACTING PARTIES TO THE GATT,
supra note 54, at 39.
56. CONTRACTING PARTIES TO GATT, Basic Instruments and Selected Documents, 30th
Supp. 147 (1986).
57. Troje Interview, supra note 40.
58. Report to the U.S. Congress on the Agreement on Technical Barriers to Trade - "Stan-
dards Code" 13 (Jan. 1983 to Dec. 1985) (on file at the MICH. J. INT'L L.).
59. Troje Interview, supra note 40.
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evidence that the closure of the article 14.25 loophole by the Commit-
tee is highly unlikely due to the fact that many countries want their
internal regulations subject to the softer GATT treatment. Further-
more, an incidental benefit of this exercise is the examination of the
substantive arguments of the parties enabling one to predict the out-
come of this dispute if it should ever reach a panel, either in a GATT
or a Standards Code context.
Article 2.1 contains the relevant substantive provision of the Stan-
dards Code which concerns the preparation, adoption, and application
of standards by central government bodies. 60 Article 2.1 enumerates
two specific obligations. First, a country may not prepare, adopt, or
apply standards which intentionally create obstacles to trade. 61 This
has not been an issue of contention between the EC and the United
States, due to the difficulty of proving intent in this specific instance
and in general. Secondly, parties to the Standards Code must ensure
that neither "standards themselves nor their application have the ef-
fect of creating unnecessary obstacles to trade."'62 This obligation en-
compasses de facto discrimination due to the language of "have the
effect." A critical word in this phrase is "unnecessary" since that
gives a party the right to adopt standards which are necessary for the
achievement of a domestic objective. The EC's position with respect
to article 2.1 is that, assuming arguendo that the Standards Code cov-
ers PPMs, the ban on the importation of meat treated with growth
hormones is necessary to protect the health of its citizens, and thus is
consistent with the Standards Code even though it may create an ob-
stacle to trade.6
3
The United States has three responses to this argument. The
United States alleges that the hormone ban is not necessary in either
one of the two senses. First, it is "unnecessary" since scientific evi-
dence does not support the conclusion that consumers are harmed by
the use of growth hormones.64 The EC counters this by claiming to
follow a "no risk" policy. 65 The validity of the EC's response rests on
the absence of scientific evidence that the use of hormones is not harm-
ful to consumers. Until a scientific body conclusively establishes the
60. Article 2.1 provides in part:
Parties shall ensure that technical regulations and standards are not prepared, adopted or
applied with a view to creating obstacles to international trade ... They shall likewise
ensure that neither technical regulations nor the standards themselves nor their application
have the effect of creating unnecessary obstacles to international trade.
Standards Code, supra note 2, at 9-10.
61. Id.
62. Id.
63. 5 Int'l Trade Rep. (BNA) 1447 (Nov. 2, 1988).
64. 4 Int'l Trade Rep. (BNA) 1184 (Sept. 30, 1987).
65. 5 Int'l Trade Rep. (BNA) 1497 (Nov. 16, 1988).
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absence of harm to consumers, the EC feels the risk is great enough to
necessitate the exclusion of hormone-treated meat from its market.
The United States secondly alleges that the import ban is "unnec-
essary" because less restrictive alternatives can be used to achieve the
same end.66 For instance, the use of testing for chemical residues
would attain the same goal of consumer protection. However, the
word "unnecessary" in article 2.1 may not encompass this type of
challenge. When one looks to the preamble of the Standards Code, the
word "necessary" connotes a causal relationship to domestic policy
rather than a least restrictive context. 67 The EC could also argue on
policy grounds that this type of challenge should not be allowed due to
a party's sovereign right to decide how best to achieve the aims. of
domestic policy. This may be especially true when one considers the
ease in which a challenger can construct a less restrictive alternative
with the benefit of hindsight.
The third United States response would resort to the preamble of
the agreement. The preamble states, in language mirroring article XX
of GATT, that a party may take measures necessary to achieve domes-
tic goals, but that these measures must not constitute a "disguised re-
striction on international trade."' 68 Given the difficulty of proving a
fraudulent intent on the part of the EC in enacting the directive, the
United States has little chance of succeeding on this ground.
In sum, the dispute over whether the enactment of the hormone
ban directive is or is not a substantive violation of the Standards Code
turns upon the issue of whether it is a necessary measure to protect EC
consumers. Both sides have presented valid arguments, and it is diffi-
cult to see how a panel might decide this question. The point to be
stressed here, however, is that the Standards Code provides a party
with the tools to mount a credible challenge to an internal regulation.
One can better appreciate the significance of this point by contrasting
the Standards Code situation to a challenge to an internal regulation
under article III of GATT.
Article III, the most relevant substantive provision of GATT, con-
tains two specific obligations. Paragraph 1 states that contracting par-
ties shall not use internal regulations "so as to afford protection to
domestic industries. ' 69 As one commentator has noted, "establishing
66. Troje Interview, supra note 40.
67. The preamble to the Standards Code states in paragraph six:
Recognizing that no country should be prevented from taking measures necessary . . . for
the protection of human, animal, or plant life .... subject to the requirement that they are
not applied in a manner which would constitute a means of arbitrary or unjustifiable dis-
crimination between countries where the same conditions prevail or a disguised restriction
on international trade.
Standards Code, supra note 2, at 8.
68. Id.
69. Article III, paragraph I provides:
The contracting parties recognize that . . .laws, regulations and requirements affecting the
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their protective effect or intent requires a review of their reasonable-
ness ... [which] necessitates difficult value judgments concerning the
legitimacy of the policy aims underlying the standards and the way in
which the standards are related to these aims."
'70
Moreover, even if a challenging party successfully made this rather
vague showing, a GATT panel might also require the party to show an
injury to its exports. A panel considering Spanish soyabean measures
first proposed the export injury test.7' In that dispute, Spain adopted
consumption quotas on soyabean oil. The panel concluded that this
was designed to protect Spanish olive oil production, but because
United States exports of soyabeans had not been restricted, American
exports experienced no adverse effect. Thus, no article III violation
was found. 72 Due to various countries' objections that article III con-
tains no injury requirement, however, the Council only noted, rather
than adopted, the panel's report. 73 Also, the panel hearing the Animal
Feeds case apparently ignored the EC's argument that there was no
injury when it found a violation of article III, providing further evi-
dence that article III may not necessarily contain an injury
requirement.
74
Paragraph 4 contains article III's second specific obligation. It re-
quires contracting parties to accord to foreign products treatment no
less favorable than that given to domestic products. 7 5 On its face, the
EC hormone ban directive is consistent with this obligation because, as
the EC is apt to tell the United States, the prohibition on the use of
hormones applies to domestic producers as well.
76
The United States has intimated, however, that the EC in fact did
not apply the directive to its domestic producers, resulting in de facto
discrimination against the United States. 77 To support their conten-
tion before a GATT panel that de facto discrimination is equally viola-
internal sale... of products ... should not be applied so as to afford protection to domestic
production.
General Agreement On Tariffs and Trade, CONTRACTING PARTIES TO GATT, Basic Instru-
ments and Selected Documents 1, at 13, 18 (1952) (hereinafter "GATT").
70. Bourgeois, supra note 42, at 8.
71. E. McGOVERN, INTERNATIONAL TRADE REGULATION 247 (2d ed. 1986) (citing Report
of panel on Spanish measures concerning domestic sale of soyabean oil, 24 O.J. EUR. COMM.
(No. L 5142) (1981)).
72. Id.
73. Id. (citing Decision of Council, 24 O.J. EUR. COMM. (No. L 5245) 32 (1981)).
74. E. MCGOVERN, supra note 71, at 247.
75. Article III, paragraph 4, states:
The products of the territory of any contracting party imported into the territory of any
other contracting party shall be accorded treatment no less favourable than that accorded to
like products of national origin in respect of all laws, regulations and requirements affecting
their internal sale ....
GATT, supra note 69, at 18.
76. 5 Int'l Trade Rep. (BNA) 1497 (Nov. 16, 1988).
77. Id.
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tive as de jure discrimination under article 111(4), the United States
could cite Schieffelin v. United States7  where an American court
hinted that de facto discrimination may form the basis of a complaint.
However, the EC could, in turn, allege that the court in Schieffelin
interpreted an FCN treaty which had a different national treatment
clause than that found in GATT. 79 Thus, the Schieffelin case may be
irrelevant to a complaint brought under Article III of GATT.
Even if the United States could establish a violation of article III
under a theory of de facto discrimination, the EC could always resort
to article XX of GATT, which allows a contracting party to escape its
GATT obligations when it pursues one of the specified domestic objec-
tives.8 0 The EC would claim that, assuming arguendo it discriminated
in fact against American goods, article XX provides a justification for
doing so, since the hormone ban is a measure to protect the welfare of
its citizens. This would force the United States to rely on arguments
that the hormone ban is not "necessary" to achieve this goal, or that
the ban is really "a disguised restriction on international trade."
It is much more difficult for a country to challenge the use of a
standard under GATT than it is to do so under the Standards Code
for two reasons. First, the Standards Code explicitly acknowledges
the theory of de facto discrimination against imported goods despite
the fact that this theory has not been definitively accepted in a GATT
application. Second, the Standards Code provides the challenging
party with a specific tool with which to attack the imposition of a
standard by including the word "unnecessarily." Under article III of
GATT, the phrase "afford protection" is vague and presents a difficult
initial hurdle. Only once a challenging party has overcome this obsta-
cle does one reach the issue of the meaning of "necessary" in article
XX. The difference in substantive treatment between the Standards
Code and GATT explains both the motivation behind the EC's insis-
78. 424 F.2d 1396, 1398-1403 (C.C.P.A. 1970). The center of the dispute in the case was the
American proof-gallon system of taxation which applied equally as a matter of law between
foreign and domestic goods, but which as a matter of fact resulted in higher taxation rates for
imported goods. The importers challenged the practice on the basis of a FCN treaty between
Ireland and the United States. The court felt itself bound by a previous case which rejected a
similar challenge under article III of GATT, the logic being that since the FCN treaty was "no
more restrictive" than GATT, the result in the previous case governs. One can infer from this
statement that the GATT national treatment clause in article III is more restrictive and thus may
apply to a broader range of internal laws which, as a matter of fact, discriminate against imports.
79. Id.
80. Article XX provides in part:
Subject to the requirement that such measures are not applied in a manner which would
constitute a means of arbitrary or unjustified discrimination between countries where the
same conditions prevail, or a disguised restriction on international trade, nothing in this
Agreement shall be construed to prevent the adoption or enforcement by any contracting
party of measures ... necessary to protect human, animal or plant life or health.
GATT, supra note 69, at 48.
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tence on their interpretation of article 14.25 and why this loophole is
unlikely to be closed anytime soon by the Committee.
CONCLUSION
The EC hormone ban dispute involves many complex procedural
and substantive issues concerning the application of the Standards
Code. The failure of this agreement's dispute settlement provisions led
to an escalation of the trade dispute by prompting both parties to con-
sider unilateral measures in an effort to preserve markets for their
exports.
The application of the dispute resolution mechanism in the Stan-
dards Code to the EC hormone ban dispute exposed two major flaws
in the process. The first flaw is the requirement that the Committee
act in consensus when handling the settlement of disputes, for it inevi-
tably allows a disgruntled party to block the process. The second
shortcoming of article 14 is the lack of a concrete interpretation of
article 14.25 which allows a party to easily evade the obligations of the
Code by drafting its internal requirements in terms of a PPM.
Shifting to a normative sense, there are reforms which should be
considered in order to ensure that standards disputes in the future are
settled in a multilateral setting without resort to unilateral measures.
First, interested parties should be required to abstain from voting in
dispute settlement procedures. Second, an attempt should be made to
formulate a concrete interpretation of article 14.25, to prevent coun-
tries from skirting their code obligations through artful legislative
drafting. This last proposed reform has little chance of being adopted
due to the difference in substantive treatment of internal regulations
by the Standards Code and under GATT.
It shall be interesting to see how the EC and the United States
resolve this dispute. Both sides set forth valid substantive arguments
in both a GATT and Standards Code context. Whatever the outcome,
the issues concerning the Standards Code which have been raised by
the EC hormone ban dispute should be resolved in a definitive manner
so as to prevent trade disputes from becoming a quid pro quo battle of
unilateral measures.
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